CAMPBELL, Calif., May 12, 2015 /PRNewswire/ — Atia Medical, Inc., a stealth mode portfolio company of medical technology incubator, Shifamed, LLC., announced today that it has raised $3M in the first tranche of its $5M in Series B financing. The investment was made fully by Medvance Incubator Partners, LLP, an early stage medtech venture fund formed by Shifamed and Delos Capital. “We are grateful for Medvance Incubator Partners’ support so that we may remain focused on product development,” shared Mariam Maghribi, CEO of Atia Medical.

About Atia Medical
Atia Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator.

About Shifamed LLC
Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. Shifamed portfolio companies include Apama Medical, Kalila Medical, Atia Medical and a number of stealth mode companies. To learn more about Shifamed, please visit

About Medvance Incubator Partners LLP
Medvance Incubator Partners LLP is an early stage venture fund created through the partnership of Shifamed LLC and Delos Capital, an Asia-based healthcare venture capital fund that seeks to pursue attractive investment opportunities in greater Asia and the U.S. The Medvance fund has been established to predominately invest in the portfolio companies of Shifamed.

Katie Arnold
SPRIG Consulting LLC
(408) 805-0520

SOURCE Atia Medical, Inc.